PharmaShots Weekly Snapshot (Jun 29 - Jul 03, 2020)
Published: Jul 03, 2020 | Tags: EC, Hepatocellular Carcinoma, Medivir, Miv-818, Orphan, Medicinal Product Designation, Receives
Published: Jul 03, 2020 | Tags: Approval, FDA, Fostemsavir, HIV, Limited, Treatment, Options, Patients, Receives, Rukobia, US, Viiv Healthcare
3. Sanofi and Regenerons Kevzara (sarilumab) Fails in P-III Trial for Patients with COVID-19 in the US
Published: Jul 03, 2020 | Tags: COVID-19, Fails, Kevzara, P-III, Patients, Regeneron, Sanofi, Sarilumab, Study, US
4. Zydus to Initiate Clinical Trials Evaluating ZyCoV-D Vaccine Against COVID-19 in July 2020
Published: Jul 03, 2020 | Tags: Zydus, Initiate, Clinical Trials, Evaluating, ZyCoV-D, Vaccine, Against, COVID-19, July 2020
Published: Jul 03, 2020 | Tags: Sarepta, Signs, Exclusive, Worldwide, License, Hansa, Develop, Imlifidase, Duchenne Muscular Dystrophy, Limb-Girdle Muscular Dystrophy
6. Helsinn and MEI Terminate its P-III Study of Pracinostat for Patients with AML
Published: Jul 03, 2020 | Tags: Helsinn, MEI, Terminate, P-III, Study, Pracinostat, Patients, AML
Published: Jul 02, 2020 | Tags: Biogen, Signs, License Agreement, Massachusetts Eye and Ear, Develop, Treatment, Inherited Retinal Disorder
8. Yuhan Collaborates with GI Innovation for its Allergy Treatment Worth up to $1.2B
Published: Jul 02, 2020 | Tags: Yuhan, Collaborates, GI Innovation, Allergy Treatment, Worth, $1.2B
9. Janssen Receives ECs Approval for its Ebola Vaccine Dual Regimen
Published: Jul 02, 2020 | Tags: Janssen, Receives, EC, Approval, Ebola Vaccine, Dual Regimen
10. Sorrento Selects T-VIVA-19 as a Targeted Protein Vaccine Candidate Against COVID-19
Published: Jul 02, 2020 | Tags: Sorrento, Selects, T-VIVA-19, Targeted, Protein Vaccine Candidate, COVID-19
Published: Jul 02, 2020 | Tags: Dr. Reddys, GRA, Collaborate, Fujifilm, Avigan, Favipiravir, Treat, COVID-19, Outside, Japan
12. Pfizer and BioNTech Report Results of BNT162b1 mRNA-Based Vaccine in P-I/II Study Against COVID-19
Published: Jul 02, 2020 | Tags: Pfizer, BioNTech, Report, Results, BNT162b1, mRNA-Based Vaccine, P-I/II, Study, Against, COVID-19
13. QurAlis Signs a License Agreement with Eli Lilly for its ALS Therapeutic Candidates
Published: Jul 02, 2020 | Tags: QurAlis, Signs, License Agreement, Eli Lilly, ALS, Therapeutic Candidates
Published: Jul 01, 2020 | Tags: Boston Scientific, Receives, US, FDA, 510(k) Clearance, LUX-Dx Insertable, Cardiac Monitor System
Published: Jul 01, 2020 | Tags: Merck KGaA, Pfizer, Bavencio, avelumab, Receives, US, FDA, Approval, 1L, Treatment, Locally Advanced, Metastatic Urothelial Carcinoma
Published: Jul 01, 2020 | Tags: Aflibercept, Eylea, Initiation P-III, Proposed Biosimilar, Reports, Samsung Bioepis, Sb15, Study
Published: Jul 01, 2020 | Tags: G1 Therapeutics, Boehringer Ingelheim, Collaborate, Co-Promote, Trilaciclib, Small Cell Lung Cancer, US, Puerto Rico
18. Takeda Collaborates with Carmine for Non-Viral Gene Therapies Worth Up to $900M
Published: Jul 01, 2020 | Tags: Takeda, Collaborates, Carmine, Non-Viral, Gene Therapies, $900M
Published: Jun 30, 2020 | Tags: Celltrion, Remsima SC, biosimilar, infliximab, Receives, CHMP, Positive Opinion, Additional, Five Indications, Inflammatory Bowel Disease, Ankylosing Spondylitis
Published: Jun 30, 2020 | Tags: Roche, Phesgo, fixed-dose combination, Perjeta, Herceptin, Receives, US, FDA, Approval, Early, Metastatic, Her2-Positive Breast Cancer
Published: Jun 30, 2020 | Tags: AstraZeneca, MSD, Selumetinib, Receives, MHLW, Orphan Drug Designation, Neurofibromatosis Type 1, Japan
Published: Jun 30, 2020 | Tags: Bharat Biotech, Initiate, Clinical Trials, Evaluating, Covaxin, India, First, COIVD-19, Vaccine, July 2020
Published: Jun 30, 2020 | Tags: Abbott, Integrate, CGM Technology, Tandem, Insulin Delivery System, Improving, Diabetes Management
24. Gilead Unveils the Price of Remdesivir as $390 per Vial in Developed Countries
Published: Jun 30, 2020 | Tags: Gilead, Unveils, Price, Remdesivir, $390, Vial, US, Developed Countries
Published: Jun 29, 2020 | Tags: Samsung Bioepis, Aybintio, biosimilar, bevacizumab, Receives, CHMP, Positive Opinion, Treat, Multiple, Cancer Indications
26. Kyowa Kirins FKB327 (biosimilar, adalimumab) Receives the MMA Approval in Japan
Published: Jun 29, 2020 | Tags: Kyowa Kirin, FKB32, biosimilar, adalimumab, Receives, the MMA, Approval, Japan
Published: Jun 29, 2020 | Tags: Roche, Enspryng, satralizumab, Receives, MHLW, Approval, Neuromyelitis Optica Spectrum Disorder, Japan
28. Alexions Ultomiris (ravulizumab) Receives ECs Approval for Atypical Hemolytic Uremic Syndrome
Published: Jun 29, 2020 | Tags: Alexion, Ultomiris, ravulizumab, Receives, EC, Approval, Atypical Hemolytic Uremic Syndrome
29. MHLW Approves Novartis Five New Therapies Expanding its Footprints in Japan
Published: Jun 29, 2020 | Tags: MHLW, Approves, Novartis, Five New, Therapies, Expanding, Footprints, Japan
30. Daiichi Sankyo in Talks with AstraZeneca for the Supply of AZD1222 to Combat COVID-19 in Japan
Published: Jun 29, 2020 | Tags: Daiichi Sankyo, Talks, AstraZeneca, Supply, AZD1222, COVID-19, Japan
Tags
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com